154 related articles for article (PubMed ID: 33874715)
1. [Clinical and prognostic features of ovarian endometrioid carcinoma with synchronous endometrial lesions].
Yao LQ; Zhou L; Dai L; Ye X; Zhu HL; Cheng HY; Ma RQ; Cui H; Chang XH
Zhonghua Fu Chan Ke Za Zhi; 2021 Mar; 56(3):200-207. PubMed ID: 33874715
[No Abstract] [Full Text] [Related]
2. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
3. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
4. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
5. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
6. The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas.
Zhan X; Li L; Wu M; Lang J
Arch Gynecol Obstet; 2019 Oct; 300(4):1045-1052. PubMed ID: 31520260
[TBL] [Abstract][Full Text] [Related]
7. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
8. Prognostic analysis for Chinese patients with stage I ovarian endometrioid carcinoma.
Zhao Y; Wang S; Qu YM; Ji YT; Shen K; Lang JH
J Ovarian Res; 2017 Sep; 10(1):63. PubMed ID: 28923080
[TBL] [Abstract][Full Text] [Related]
9. FIGO Versus Silverberg Grading Systems in Ovarian Endometrioid Carcinoma: A Comparative Prognostic Analysis.
Parra-Herran C; Bassiouny D; Vicus D; Olkhov-Mitsel E; Cesari M; Ismiil N; Nofech-Mozes S
Am J Surg Pathol; 2019 Feb; 43(2):161-167. PubMed ID: 30212391
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer.
Matsuo K; Machida H; Frimer M; Marcus JZ; Pejovic T; Roman LD; Wright JD
Gynecol Oncol; 2017 Dec; 147(3):558-564. PubMed ID: 28986093
[TBL] [Abstract][Full Text] [Related]
11. Synchronous dual primary ovarian and endometrial carcinomas.
Pearl ML; Johnston CM; Frank TS; Roberts JA
Int J Gynaecol Obstet; 1993 Dec; 43(3):305-12. PubMed ID: 7907042
[TBL] [Abstract][Full Text] [Related]
12. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; McKee B; Hoskins WJ; Barakat RR
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):79-85. PubMed ID: 12182977
[TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic factors in patients with synchronous ovarian and endometrial cancers and endometrial cancers metastatic to the ovaries.
Ayhan A; Guvenal T; Coskun F; Basaran M; Salman MC
Eur J Gynaecol Oncol; 2003; 24(2):171-4. PubMed ID: 12701972
[TBL] [Abstract][Full Text] [Related]
14. TCGA molecular subgroups of endometrial carcinoma in ovarian endometrioid carcinoma: A quantitative systematic review.
D'Alessandris N; Travaglino A; Santoro A; Arciuolo D; Scaglione G; Raffone A; Inzani F; Zannoni GF
Gynecol Oncol; 2021 Nov; 163(2):427-432. PubMed ID: 34446267
[TBL] [Abstract][Full Text] [Related]
15. Synchronous ovarian and endometrial carcinoma: a strong link to endometriosis?
Kondi-Pafiti A; Grapsa D; Liapis A; Papadias K; Kairi-Vassilatou E; Hasiakos D
Eur J Gynaecol Oncol; 2008; 29(3):256-9. PubMed ID: 18592790
[TBL] [Abstract][Full Text] [Related]
16. Does synchronous endometrioid endometrial cancer have any prognostic effect on Stage I endometrioid ovarian cancer?
Narin MA; Karalok A; Basaran D; Ureyen I; Turkmen O; Turan T; Tulunay G
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():113-6. PubMed ID: 27017531
[TBL] [Abstract][Full Text] [Related]
17. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of stage I ovarian clear cell and endometrioid carcinomas arising from endometriotic cysts: is it a myth?
Ayhan A; Akilli H; Haberal N
Arch Gynecol Obstet; 2019 Jan; 299(1):217-222. PubMed ID: 30315413
[TBL] [Abstract][Full Text] [Related]
19. Prognosis Trend of Grade 2 Endometrioid Endometrial Carcinoma: Toward Grade 1 or 3?
Khatib G; Gulec UK; Guzel AB; Bagir E; Paydas S; Vardar MA
Pathol Oncol Res; 2020 Oct; 26(4):2351-2356. PubMed ID: 32488809
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma.
Yoneoka Y; Yoshida H; Ishikawa M; Shimizu H; Uehara T; Murakami T; Kato T
J Gynecol Oncol; 2019 Jan; 30(1):e7. PubMed ID: 30479091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]